Stay updated with breaking news from Aptorum Group Or. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aptorum Group Limited , a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, announced the results of its...
Aptorum Group Limited , a clinical-stage biopharmaceutical company, announced that it has received an approval letter from the Nasdaq Stock Market LLC Listing Qualifications Department notifying... -Today at 02:58 am- MarketScreener
Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company focused on novel technologies including the targeting of oncological diseases, announced that the group has submitted t...
Regulatory News: Aptorum Group Limited , a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today... | May 5, 2023
Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology